p38 kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas.
A M Redman, J S Johnson, R Dally, S Swartz, H Wild, H Paulsen, Y Caringal, D Gunn, J Renick, M Osterhout, J Kingery-Wood, R A Smith, W Lee, J Dumas, S M Wilhelm, T J Housley, A Bhargava, G E Ranges, A Shrikhande, D Young, M Bombara, W J Scott
Index: Bioorg. Med. Chem. Lett. 11(1) , 9-12, (2001)
Full Text: HTML
Abstract
Inhibitors of the MAP kinase p38 are potentially useful for the treatment for osteoporosis, arthritis, and other inflammatory diseases. A series of thienyl, furyl, and pyrrolyl ureas has been identified as potent p38 inhibitors, displaying in vitro activity in the nanomolar range.
Related Compounds
Related Articles:
A short synthesis of quinazolinocarboline alkaloids rutaecarpine, hortiacine, euxylophoricine A and euxylophoricine D from methyl N-(4-chloro-5H-1, 2, 3-dithiazol-5-ylidene) anthranilates. Mohanta PK and Kim K.
[Tetrahedron Lett. 43(22) , 3993-96, (2002)]
Synthesis and Properties of Some New 1, 4-Dihydrothieno [3, 2-e][1, 2, 4] triazepin-5-ones. Sabri SS, et al.
[Z. Naturforsch. B 61(1) , 65, (2006)]
2006-09-15
[Bioorg. Med. Chem. Lett. 16(18) , 4723-27, (2006)]